Zhaoxue Yu

Dr. Zhaoxue (Luke) Yu joined Biocytogen as Global Head of Preclinical Pharmacology in 2020. Dr. Yu brings more than 15 years of research and technical leadership experience in drug discovery and development for immune/autoimmune diseases, oncology, neurological diseases, ocular diseases and metabolic diseases across various therapeutic modalities including antibodies, biologics, small molecules, mRNAs, and AAVs. Prior to Biocytogen, Dr. Yu served as a pharmacology technical leader at Gemini Pharmaceuticals, Achillion Pharmaceuticals, and Alexion Pharmaceuticals. Dr. Yu has been a major contributor to multiple drug development programs from preclinical to clinical stages, some of which have subsequently obtained success approvals by the FDA. Dr. Yu received his Ph.D in Neurobiology and M.D. in China. He has held postdoctoral research positions at institutions including Emory University, Yale University, and Harvard Boston Children’s Hospital.